Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Evolan Pharma AB

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 1,033,992 Less Arrow 960,999 Less Arrow 697,061
Financial expenses 7,249 More Arrow 8,579 Less Arrow 1,668
Earnings before taxes 340,498 Less Arrow 291,278 Less Arrow 221,228
EBITDA 427,429 Less Arrow 405,260 Less Arrow 290,042
Total assets 1,249,029 Less Arrow 1,030,730 Less Arrow 816,768
Current assets 1,056,285 Less Arrow 753,699 Less Arrow 465,538
Current liabilities 217,963 More Arrow 230,575 Less Arrow 202,186
Equity capital 970,329 Less Arrow 740,494 Less Arrow 498,965
- share capital 103 Less Arrow 101 Less Arrow 95
Employees (average) 28 More Arrow 29 Less Arrow 27

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 77.7% Less Arrow 71.8% Less Arrow 61.1%
Turnover per employee 36,928 Less Arrow 33,138 Less Arrow 25,817
Profit as a percentage of turnover 32.9% Less Arrow 30.3% More Arrow 31.7%
Return on assets (ROA) 27.8% More Arrow 29.1% Less Arrow 27.3%
Current ratio 484.6% Less Arrow 326.9% Less Arrow 230.3%
Return on equity (ROE) 35.1% More Arrow 39.3% More Arrow 44.3%
Change turnover 55,665 More Arrow 214,477 Less Arrow 64,547
Change turnover % 6% More Arrow 29% Less Arrow 10%
Chg. No. of employees -1 More Arrow 2 Less Arrow 0
Chg. No. of employees % -3% More Arrow 7% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.